Biotech News

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

Arcutis Biotherapeutics (ARQT)Arcutis BiotherapeuticsCommercial

Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin health Biles’ treatment, ZORYVE ® (roflumilast), is the #1 prescribed branded topical therapy for three major inflammatory skin conditions combined — seborrheic dermatitis,

Related news

Arcutis Biotherapeutics

Medical Dermatology Arcutis Biotherapeutics develops and commercializes targeted therapies for immune-mediated skin diseases, emphasizing convenient topical formulations against validated biology. ZORYVE Franchise ZORYVE is a once-daily topical roflumilast product available in cream and foam formulations across plaque psoriasis, atopic...

Recent company news

Stock data

Close
25.29 USD
Market cap
2.6B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States